Preparation and Biological Evaluation of 10B-Enriched 3-[5-{2-(2,3-Dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a New Boron Delivery Agent for Boron Neutron Capture Therapy of Brain Tumors
- 11 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (18), 5513-5523
- https://doi.org/10.1021/jm060413w
Abstract
3-[5-{2-(2,3-Dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (compound 1, N5-2OH) belongs to a novel class of boron delivery agents for neutron capture therapy, which was designated 3-carboranylthymidine analogue (3CTAs). Two shorter and more convenient synthetic routes were developed for the synthesis of 1 in the 10B-enriched form, which is necessary for its preclinical and clinical evaluation in neutron irradiation studies. For more insight on structure−activity relationships, various stereochemical and geometrical isomers of 1 were synthesized and their specificities as substrate for human thymidine kinase 1 (hTK1) were evaluated. A computational model for the binding of various isomers of 1 to the active site of hTK1 was developed. Preliminary studies carried out in F98 glioma bearing rats that had received a 10B-enriched form of 1 followed by neutron irradiation demonstrated a significant prolongation in survival times compared to control animals, suggesting that further studies are warranted to evaluate the therapeutic potential of 1.Keywords
This publication has 34 references indexed in Scilit:
- Boron Neutron Capture Therapy of Cancer: Current Status and Future ProspectsClinical Cancer Research, 2005
- Synthesis and Biological Evaluation of Neutral and Zwitterionic 3-Carboranyl Thymidine Analogues for Boron Neutron Capture TherapyJournal of Medicinal Chemistry, 2005
- Molecular Mechanisms of Glioma Cell Migration and InvasionJournal of Neuro-Oncology, 2004
- Current management of glioblastoma multiformeSeminars in Oncology, 2004
- Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural propertiesBioorganic & Medicinal Chemistry, 2004
- The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 positionApplied Radiation and Isotopes, 2004
- Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agentsExpert Review of Neurotherapeutics, 2004
- Cost of Migration: Invasion of Malignant Gliomas and Implications for TreatmentJournal of Clinical Oncology, 2003
- Primary brain tumours in adultsThe Lancet, 2003
- Synthesis of 5-(Carboranylalkylmercapto)-2‘-deoxyuridines and 3-(Carboranylalkyl)thymidines and Their Evaluation as Substrates for Human Thymidine Kinases 1 and 2Journal of Medicinal Chemistry, 1999